Latest News

Filters

Filter by tags: Iodine-131 Clear all tag filters

51 news articles found

Rosatom has completed construction of the building for a new plant for the production of medical isotope products at the Karpov Scientific Research Institute of Physics & Chemistry in Obninsk, Kaluga region. The plant will be largest radio pharmaceutical factory in Europe. Construction began in 2023 and the plant is expected to begin operation in 2025 producing 25 items.

Source: NEI Magazine
Date: Thursday, 08 February 2024
Original article: neimagazine.com/news/newsbuilding-for-obninsk-radiopharmaceutical-plant-completed-11494076

Russia's Ministry of Industry and Trade, representatives from the Kaluga region and the city of Obninsk, and Rosatom have signed a special investment contract for the construction of what Rosatom says will be Europe's largest plant for the production of radiopharmaceuticals.

Source: World Nuclear News
Date: Wednesday, 11 October 2023
Original article: world-nuclear-news.org/Articles/Special-investment-contract-signed-for-Russian-med

Russia’s Kursk NPP has sent the first batch of cobalt-60 (Co-60) for shipment to the customer. The material was transported in specialised containers to a redistribution centre for delivery to the customer. The shipment is enough to sterilise at least 15,000 cubic metres of medical devices.

Source: NEI Magazine
Date: Wednesday, 26 July 2023
Original article: neimagazine.com/news/newskursk-npp-delivers-first-batch-of-cobalt-60-isotope-11027702

International Atomic Energy Agency (IAEA) Director General Rafael Mariano Grossi says IAEA experts present at Ukraine’s Zaporizhia NPP (ZNPP) have in recent days and weeks inspected parts of the facility – including some sections of the perimeter of the large cooling pond – and have also conducted regular walkdowns across the site, so far without observing any visible indications of mines or explosives.

Source: NEI Magazine
Date: Friday, 07 July 2023
Original article: neimagazine.com/news/newsattack-on-zaporizhia-npp-may-have-been-averted-10988247

Russian nuclear utility Rosenergoatom (Electric Power Division of Rosatom) is expanding the range of radioactive isotopes produced at NPPs. In the near future, the production of the radioactive isotope samarium-153 will be launched at the Leningrad NPP. Radiopharmaceuticals based on samarium-153 (Sm-153) are widely used in nuclear medicine to reduce pain in bone metastases to provide palliative care to cancer patients, as well as in traumatology for chronic diseases of the musculoskeletal system.

Source: NEI Magazine
Date: Wednesday, 21 June 2023
Original article: neimagazine.com/news/newsleningrad-npp-to-expand-medical-radioisotope-production-10952159

Production of medical isotopes - iodine-131 (I-131) and molybdenum-99 (Mo-99) is to begin at Russia’s Smolensk and Kursk NPPs following discussions held at Leningrad NPP. Participants included representatives of nuclear utility Rosenergoatom, specialists from the Leningrad, Smolensk and Kursk plants and equipment developers from the NA Dollezhal Scientific Research & Design Institute of Power Engineering (Nikiet).

Source: NEI Magazine
Date: Thursday, 15 June 2023
Original article: neimagazine.com/news/newsrosenergoatom-to-produce-medical-isotopes-at-two-more-npps-10941177

The Korea Atomic Energy Research Institute (KAERI) has said that first concrete has been poured for its Kijang Research Reactor (KJRR) at the Radiology Science Industrial Complex in Gijang-gun, Busan.

Source: NEI Magazine
Date: Wednesday, 10 May 2023
Original article: neimagazine.com/news/newsfirst-concrete-for-koreas-new-research-reactor-10831766

Seoul announces construction start at KJRR in Busan

Source: Nucnet
Date: Saturday, 06 May 2023
Original article: nucnet.org/news/new-research-reactor-to-boost-production-of-crucial-medical-radioisotopes-5-5-2023

The first concrete has been poured for the Kijang Research Reactor (KJRR) at the Radiology Science Industrial Complex in Gijang-gun, Busan, the Korea Atomic Energy Research Institute (KAERI) announced.

Source: World Nuclear News
Date: Thursday, 04 May 2023
Original article: world-nuclear-news.org/Articles/Korea-starts-construction-of-new-research-reactor

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Source: Nucnet
Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Load more news